Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- France
- Sweden
- Spain
- Netherlands
- Poland
- Portugal
- Finland
- Belgium
- Switzerland
- Canada
- Italy
- Austria
- Norway
- Denmark
- Morocco
- Singapore
- Czech
- United Arab Emirates
- Australia
- Brazil
- Japan
- Ireland
- Hong Kong
- India
- Luxembourg
- South Africa
- China
- Hungary
- Latvia
- Croatia
- Greece
- Malta
- Mexico
- New Zealand
- Romania
- Slovenia
- South Korea
- Taiwan
- 31 more »
- « less
-
Program
-
Field
-
to study the molecular and cellular mechanisms in neuronal cells that can be potentially targeted to prevent, alleviate, and promote recovery from ischemic stroke. The successful candidate will work with
-
the development of therapeutic strategies to promote neurological recovery. The successful candidate will use a combination of in vivo and in vitro approaches, including animal models, molecular and
-
staging systems, including integrated morpho-molecular models; enhancing institutional and multicentre case series through national and international collaborations; generating evidence through clinico
-
Postdoctoral Research Associate, Cellular and Molecular Medicine (Full-Time) Posting Number req26851 Department Cellular & Molecular Medicine Department Website Link https://cmm.arizona.edu/ Location Tucson
-
mechanisms underlying pain, peripheral neuropathies, and neurodegenerative diseases. Our research uses animal models, cell culture, molecular and histological approaches, and transcriptomic analyses to better
-
. The Sun Lab uses multidisciplinary approaches, spanning microbial genetics, cell biology, immunology, high-throughput screening, omics, and in vivo models, to study host immunity to pathogens (such as
-
cause virulence. We apply interdisciplinary approaches, including genomics, metabolomics, molecular microbiology, microscopy, and pathogenesis studies using mouse models to address these questions. Job
-
address these questions using TFE3-rearranged renal cell carcinoma (tRCC) as a unique model of transcription factor-driven cancer. The successful candidate will combine mechanistic molecular biology
-
FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL | Spain | 12 days ago
are exploring an emerging therapeutic target to reduce fibrosis and intramuscular, fat accumulation in DMD, and we have to validate this target in in vitro and in vivo dystrophic models we aim to decipher
-
shape the brain’s trajectory in health and disease. More information about the lab and their work can be found by visiting https://www.jin.scripps.edu/ About the Research Technician II role: As the